Physician

Camille N Abboud, MD

According to 2025 Medicare claims, Camille Abboud, MD (NPI: 1316965320) practices medical oncology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Clair, IL. This provider's primary affiliated billing organization is WASHINGTON UNIVERSITY PHYSICIANS IN ILLINOIS, INC (NPI: 1477076263; TIN: 822026363) and primary practice location at 62269-2998. Abboud is affiliated with the BJC HealthCare ACO, LLC (ACO ID: A1204), IRCCO (ACO ID: A2619), and SSM IL ACO, LLC (ACO ID: A4832), participating under the MSSP model.

Abboud's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 158 traditional Medicare patients, billed 3,594 HCPCS/CPT codes, and received $87,007 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,944 prescription claims across 189 beneficiaries totaling $9,932,994 in drug costs, led by Brukinsa (Zanubrutinib). 2022 DME data shows 12 claims. Open Payments data shows 11 records totaling $1,973,738. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $481,774 and ending at $87,007. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $573,202 to $9,932,994. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	367	32,695	$481,774
2016	336	33,098	$625,484
2017	332	30,645	$583,760
2018	259	59,571	$695,472
2019	278	65,395	$1,222,830
2020	260	57,415	$1,318,519
2021	288	56,060	$1,064,134
2022	240	47,843	$826,232
2023	275	46,918	$1,002,349
2024	158	3,594	$87,007

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	105	972	$573,202
2016	88	830	$669,523
2017	112	1,034	$994,936
2018	107	1,236	$1,585,622
2019	133	1,197	$2,913,400
2020	114	1,169	$3,888,689
2021	132	1,403	$4,888,465
2022	147	1,373	$5,933,536
2023	203	2,024	$8,762,449
2024	189	1,944	$9,932,994

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	84	$20,128
2016	N/R	12	$3,647
2017	N/R	11	$207
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$9,857
2021	N/R	12	$9,943
2022	N/R	12	$10,134
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	19	19	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	129	262	$92
36415	Insertion of needle into vein for collection of blood sample	33	69	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	196	5,880	$2,758,668
Revlimid	Lenalidomide	82	2,262	$1,463,153
Jakafi	Ruxolitinib Phosphate	49	1,590	$850,721
Calquence	Acalabrutinib Maleate	45	1,350	$685,082
Scemblix	Asciminib Hydrochloride	27	810	$564,617

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$1,426	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$1,972,312	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Camille N. Abboud, MD?

Tedicare shows public-source Medicare data for Camille N. Abboud, MD (NPI 1316965320), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Camille N. Abboud, MD have ACO affiliation data?

Camille N. Abboud, MD is shown with ACO affiliation data for BJC HealthCare ACO, LLC (MSSP, ACO ID A1204), IRCCO (MSSP, ACO ID A2619), and SSM IL ACO, LLC (MSSP, ACO ID A4832).

What billing organization is linked to Camille N. Abboud, MD?

Camille N. Abboud, MD is linked to WASHINGTON UNIVERSITY PHYSICIANS IN ILLINOIS, INC (billing NPI 1477076263) in the available physician profile data.

Does Camille N. Abboud, MD have Open Payments data?

Camille N. Abboud, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.